Article
Neonatal vitamin K administration and in vivo somatic mutation.
Mutation research - 1 Aug 1995
Pizer B, Boyse J, Hunt L, Mott M
Abstract excerpt
The glycophorin A (GPA) mutation assay was used to examine the risk of in vivo somatic mutation in infants following neonatal administration of vitamin K. The assay assesses damage to erythroid stem cells by measuring the frequency of NO and NN variant red cells of MN blood group heterozygotes using FACS analysis. Blood samples were obtained from 178 infants aged between 10 and 183 days. Twenty-six children were...
Topics
- Administration, Oral
- Erythrocytes
- Flow Cytometry
- Follow-Up Studies
- Genetic Variation
- Glycophorins
- Hematopoietic Stem Cells
- Heterozygote
- Humans
- Infant
- Infant, Newborn
- Injections, Intramuscular
